Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: A possible pathological role for enhanced oxidative stress in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3096-3102

  Nakayama, Masaaki ^a   Nakayama, Keisuke ^a   Zhu, Wan Jun ^a   Shirota, Yuko ^b   Terawaki, Hiroyuki ^a   Sato, Toshinobu ^b   Kohno, Masahiro ^c   Ito, Sadayoshi ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Hydrogen peroxide; Methylglyoxal; Oxidative stress; Polymorphonuclear leukocyte

Indexed keywords

HYDROGEN PEROXIDE; METHYLGLYOXAL;

ARTICLE; CELL VIABILITY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL;

APOPTOSIS; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; DRUG SYNERGISM; FREE RADICALS; HUMANS; HYDROGEN PEROXIDE; KIDNEY FAILURE, CHRONIC; NECROSIS; NEUTROPHILS; OXIDATIVE STRESS; PYRUVALDEHYDE; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE;

EID: 52449121509     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn218     Document Type: Article

References (32)

1. K/DOQI: Kidney Disease Outcome Quality Initiative. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S246
2. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
3. GO AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and the hospitalization. New Engl J Med 2004; 351: 296-305
4. Ninomiya T, Kiyohara Y, Kubo M et al. Choronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228-236
5. Nakayama M, Metoki H, Terawaki H et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in general Japanese population - the Ohasama study. Neprol Dial Transplant 2007; 22: 1910-1915
6. US Renal data System: USRDS 2005 Annual Data Report. Atlas of end-stage renal disease in the United States, Bethesda, National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 2005
7. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
8. Pecoits-Filho R, Barany P, Lindholm B et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688
9. Oberg BP, McMenamin E, Lucas L et al. Increased prevalence of oxidant stress and inflammation inpatients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016
10. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif 2005; 23: 64-71
11. Yilmaz ML, Saglm M, Caglar K et al. The determinants of endothelial disfunction in CKD: oxidative stress and asymmetric dimethylarginnine. Am J Kidney Dis 2006; 47: 42-50
12. Sela S, Shurtz-Swirski R, Choen-Mazor M et al. Kristal B primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-2438
13. Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1995; 5: 1697-1702
14. Borawski J. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the understimated modifying effects of heparin. Am J Kidney Dis 2006; 47: 37-41
15. Maruyama Y, Lindholm B, Stenvinkel P. Inflammation and oxidative stress in ESRD-the role of myeloperoxidase. J Nephrol 2004; 17: S1-S5
16. Anding K, Gross P, Rost JM et al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephlo Dial Trasnplant 2003; 18: 2067-2073
17. Jacobi J, Sela S, Cohen HI et al. Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol 2006; 290: H2051-H2058
18. Odani H, Shinzato T, Matsumoto Y et al. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 1999; 256: 89-93
19. Lapolla A, Flamini R, Lupo A et al. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis. Ann N Y Acad Sci 2005; 1043: 217-224
20. Bourajja M, Stehouwer CD, van Hinsbergh VWet al. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans 2003; 31: 1400-1402
21. Fukunaga M, Miyata S, Liu BF et al. Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochem Biophys Res Commun 2004; 320: 689-695
22. Okada A, Kawashima Y, Hasuike Y et al. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 1996; 225: 219-224
23. Chan WH, Wu HJ. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem 2007; 100: 1056-1069.
24. Sheader EA, Benson RSP, Best L. Cytotoxic action of methylglyoxal on insulin-secreting cells. Biochem Pharmacol 2001; 61: 1381-1386
25. Gawlowski T, Stratmann B, Stirban AO et al. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res 2007; 121: 117-126
26. Chan WH, Wu HJ. Methylglyoxal and high glucose co-treatment induces apoptosis or necrosis in human umbilical vein endothelial cells. J Cell Biochem 2008; 103: 1144-1157
27. Nakayama M, Saito K, Sato E et al. Radical generation by the nonenzymatic reaction of methylglyoxal and hydrogen peroxide. Redox Rep 2007; 12: 125-133
28. Crouch SPM, Kozlowski R, Slater KJ et al. The use of ATP bioluminescence as ameasure of cell proliferation and cytotoxicity. J Immunol Methods 1993; 160: 81-88
29. Nakayama K, Nakayama M, Terawaki H et al. Alpha-oxoaldehydes in haemodialysis solution. Nephrol Dial Transplant 2007; 22: 2097-2098
30. Perianayagam MC, Balakrishnan VS, Guo D et al. Quantification of Bax and Bc12 in polymorphonuclear leukocytes from haemodialysis patients: relation to hydrogen peroxide. Eur J Clin Invest 2003; 33: 905-911
31. Terawaki H, Yoshimura K, Hasegawa T et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004; 66: 1988-1993
32. Dounousi E, Papavasiliou E, Makedou A et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 2006; 48: 752-760